COVID-19 has impacted the clinical trial landscape dramatically. In this interview with Applied Clinical Trials, John Potthoff discusses how Elligo’s tech-enabled solutions prepared sponsors and physicians to move to decentralized or hybrid trials during COVID-19 and how these solutions could affect the future of clinical trials.
Video